BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23640206)

  • 1. Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas.
    O'Donnell PW; Manivel JC; Cheng EY; Clohisy DR
    Clin Orthop Relat Res; 2014 Mar; 472(3):849-55. PubMed ID: 23640206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
    Wang B; Yu X; Xu S; Xu M
    Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
    Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
    Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
    Tanaka K; Ozaki T
    Jpn J Clin Oncol; 2021 Feb; 51(2):180-184. PubMed ID: 33313851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of neoadjuvant chemotherapy in intermediate/high-grade soft-tissue sarcomas in the adult].
    Mori S; Apice G; Ottaiano A; De Chiara A; Germano A; Botti G; De Rosa V; Ravo V; Morrica B; Mozzillo N
    Tumori; 2003; 89(4 Suppl):267-8. PubMed ID: 12903615
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adjuvant chemotherapy of soft tissue sarcoma].
    Lévy E; Thirion P; Piedbois P
    Cancer Radiother; 1997; 1(5):462-6. PubMed ID: 9587378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.
    Tanaka K; Mizusawa J; Naka N; Kawai A; Katagiri H; Hiruma T; Matsumoto Y; Tsuchiya H; Nakayama R; Hatano H; Emori M; Watanuki M; Yoshida Y; Okamoto T; Abe S; Asanuma K; Yokoyama R; Hiraga H; Yonemoto T; Morii T; Ae K; Nagano A; Yoshikawa H; Fukuda H; Ozaki T; Iwamoto Y
    BMC Cancer; 2019 Sep; 19(1):890. PubMed ID: 31492159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
    Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
    Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.
    Davis EJ; Chugh R; Zhao L; Lucas DR; Biermann JS; Zalupski MM; Feng M; Wong SL; Jacobson J; Zyczynski L; Reinke D; Metko G; Baker LH; Schuetze SM
    Eur J Cancer; 2015 Sep; 51(13):1794-802. PubMed ID: 26066736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.
    Grobmyer SR; Maki RG; Demetri GD; Mazumdar M; Riedel E; Brennan MF; Singer S
    Ann Oncol; 2004 Nov; 15(11):1667-72. PubMed ID: 15520069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
    Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
    Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
    Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
    Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
    Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
    Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
    Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
    Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.
    Frustaci S; Gherlinzoni F; De Paoli A; Bonetti M; Azzarelli A; Comandone A; Olmi P; Buonadonna A; Pignatti G; Barbieri E; Apice G; Zmerly H; Serraino D; Picci P
    J Clin Oncol; 2001 Mar; 19(5):1238-47. PubMed ID: 11230464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304).
    Tanaka K; Mizusawa J; Fukuda H; Araki N; Chuman H; Takahashi M; Ozaki T; Hiruma T; Tsuchiya H; Morioka H; Hatano H; Iwamoto Y
    Jpn J Clin Oncol; 2015 Jun; 45(6):555-61. PubMed ID: 25838293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement and prediction of the short-term response of soft tissue sarcomas to chemotherapy.
    Schmidt RA; Conrad EU; Collins C; Rabinovitch P; Finney A
    Cancer; 1993 Nov; 72(9):2593-601. PubMed ID: 8402481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.